Lux Biosciences, Inc. has announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniq (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.
Team members of The Surgeless Sultans, The Diffractive Devils, The Chopping Conquerors and The Bursting Buccaneers will be given four minutes to talk about their most challenging cataract/complication cataract case ? with a little help from a video?
People with diabetes have an increased risk of blindness, yet nearly half of the approximately 23 million Americans with diabetes do not get an annual eye exam to detect possible problems. But it appears that cost-effective computerized systems to detect early eye problems related to diabetes can help meet the screening need, University of Iowa analysis shows.
Restaurant
Hotel
Bar
Online research in the Archives of Opthalmology has reported that contact lenses for infants who had undergone surgery for unilateral congenital cataracts resulted in similar visual outcomes for those who received an IOL implant.
Seeing
The first femtosecond-only method of laser vision correction from Carl Zeiss Meditec is now available for sale outside the United States.
Phrases
Eat Berlin
The UK's National Health Service (NHS) is reported to be looking at the use of Avastin in lieu of Lucentis.
Reader Survey 2010
See Berlin
Speak Berlin
Drink Berlin
Stay Berlin
Posterior lamellar keratoplasty with DSAEK is a new surgical technique for the treatment of endothelial corneal diseases.
TearScience, has completed a $44.5 million of Series C funding from new investors.
Optos's scanning laser ophthalmoscope devices, the P200, P200C and P200MA have been used in a number of clinical studies, aimed at evaluating the effectiveness of an optomap ultra-widefield retinal scan in detecting potentially harmful lesions in the retina.
Highlighting the many developments from the burgeoning field of oculogenetics, Dr Edwin M. Stone, PhD, focuses on a successful gene therapy experiment, the increasing availability of clinical trials, and new technology that enhances genetic testing.
An approach to pre-treating two corneal conditions that makes for better refractive surgery by Asim Piracha, MD, Louisville, Kentucky, has been published in the Review of Ophthalmology.
The World Congress on Controversies In Ophthalmology (COPHy) will take place in Barcelona, Spain, from 3?6 March 2011, following the first event held in the Czech Republic in March this year.
The new AlphaSphere Orbital Implant ophthalmic device has been awarded the 2010 Alpha Award for Innovation In Engineering & Technology presented by the Engineering Society of Detroit.
Critical Health has announced that Retmarker, its software solution for decision support in the ophthalmology domain, attained the right to hold the CE 0197 branding, that classifies it as a Class IIa Medical Device at a European level.
"Why was Lucentis, at $2000 per dose chosen for the study, rather than Avastin at $50 per dose?? so asked Irv Arons in his blog spot.
As the World Ophthalmology Congress in Berlin approaches look out for OTEurope's special interactive preview issue
Arnall Patz, MD, might not have had instant name recognition among most Americans, but among ophthalmologists, he was a legend.
Left untreated, dry eye can cause many problems in the post operative period. As many as 33 million adults may be undiagnosed
Critical consideration based on the literature and studies
